{
    "title": "Moderna forecasts COVID sales decline as costs rise, shares fall",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-11784697/Moderna-reaffirms-2023-COVID-vaccine-sales-forecast-5-billion.html",
    "date": "2023-02-23",
    "keywords": [
        "year",
        "vaccine",
        "company",
        "profit",
        "royalty",
        "payment",
        "leo",
        "loss",
        "covid",
        "analyst",
        "moderna",
        "development",
        "covid19",
        "nih",
        "share",
        "flu",
        "inc",
        "forecast",
        "revenue",
        "michael",
        "note",
        "cash",
        "flow",
        "purchase",
        "yee",
        "fourthquarter",
        "street",
        "margin",
        "health",
        "percentage",
        "forward",
        "research",
        "hartaj",
        "singh",
        "price",
        "risk",
        "product",
        "demand",
        "cancer",
        "virus",
        "rsv",
        "reliance",
        "approval",
        "season",
        "catchup",
        "patent",
        "dispute",
        "agreement",
        "hit",
        "inventory",
        "shift",
        "aditya",
        "samal",
        "leroy",
        "wingrove",
        "york",
        "editing",
        "bill",
        "berkrot"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}